Local anesthesia and malignant hyperthermia: Review of the literature and recommendations for the dermatologic surgeon

Dermatologic Surgery

Volumn 25, Issue 8, 1999, Pages 626-630

  Murray, Christian ^a   Sasaki, Steven S ^b   Berg, Daniel ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

BASAL METABOLIC RATE; DENTISTRY; HUMAN; LOCAL ANESTHESIA; MALIGNANT HYPERTHERMIA; METABOLIC REGULATION; MUSCLE RIGIDITY; OXYGEN CONSUMPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; STRESS; THERMOREGULATION;

ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; EPINEPHRINE; HUMANS; MALIGNANT HYPERTHERMIA; RISK FACTORS; SKIN DISEASES; STRESS;

EID: 0032864452     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.1999.98214.x     Document Type: Review

References (43)

1. Denborough M, Lovell R. Anesthesia deaths in a family. Lancet 1960;2:45.
2. Hall L, Woolf N, Bradley J, et al. Unusual reaction to suxamethonium chloride. Br J Med 1966;2:1305.
3. MacLennan D, Phillips M. Malignant hyperthermia. Science 1992; 256:789-94.
4. Minasian A, Yagiela J. The use of amide local anesthetics in patients susceptible to malignant hyperthermia. Oral Surg Oral Med Oral Pathol 1988;66:405-15.
5. Eslambochi S. Malignant hyperthermia. Its importance with respect to dentistry. Univ Toronto Dent J 1991;5:24-30.
6. Hindle A. Malignant hyperthermia in oral surgery - case report and literature review. Br J Oral Maxillofac Surg 1994;32:190-93.
7. Larach M, Localio A, Allen G, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80:771-9.
8. Kaus S, Rockoff M. Malignant hyperthermia. Pediatr Clin N Am 1994;41:221-36.
9. Gronert G, Antognini J. Malignant hyperthermia. In: Miller R, ed. Anesthesia, 4th ed. New York: Churchill Livingstone, 1994:1075-94.
10. Strazis K, Fox A. Malignant hyperthermia: a review of published cases. Anesth Analg 1993;77:297-304.
11. Allen G. Malignant hyperthermia and associated disorders. Curr Opin Rheumatol 1993;5:719-24.
12. McCarthy TV, Healy JMS, Heffron J, et al. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990;343:562-4.
13. Hogan K. Molecular medicine and malignant hyperthermia. Anesthesiology 1997;86:511-3.
14. Herman-Patterson T. Neuroleptic malignant syndrome and malignant hyperthermia. Med Clin N Am 1993;77:477-93.
15. Haas D, Young E, Harper D. Malignant hyperthermia and the general dentist: current recommendations. J Can Dent Assoc 1992;58:28-33.
16. Michelson J, Louis C. Malignant hyperthermia: excitation-contraction coupling, calcium release channel, and regulation defects. Physiol Rev 1996;76:537-92.
17. Ording H. Incidence of malignant hyperthermia in Denmark. Anesth Analg 1985;64:700.
18. Rosenberg H, Gronert G. Intractable cardiac arrest in children given succinylcholine. Anesthesiology 1992;77:1054.
19. Winder R, Simon J, Singard D. Malignant hyperthermia and stress: a concern in dental therapy. J Pedod 1979;3:142-54.
20. Dershwitz M, Ryan J, Guralnick W. Safety of amide local anesthetics in patients susceptible to malignant hyperthermia. J Am Dent Assoc 1989;118:277-9.
21. D'Ambrosio J, Adragna M. Guidelines for the use of local anesthetics in the dental treatment of patients who are susceptible to malignant hyperthermia. Special Care Dent 1988;2:61-3.
22. Cannell H, Walters H, Beckey A, et al. Circulating levels of lignocaine after perioral injections. Br J Dent 1975;138:87-93.
23. Covino B. Local anesthetic agents. In: Attia R, Grogono A, eds. Practical anesthetic pharmacology. New York: Appleton-Century-Crofts, 1978:70-109.
24. Harrison G, Morrell D. Response of MHS swine to IV infusion of lignocaine and bupivacaine. Br J Anaesth 1980;52:385-7.
25. Wingard D, Bobko S. Failure of lidocaine to trigger porcine malignant hyperthermia. Anesth Analg 1979;59:99-103.
26. Berkowitz A, Rosenberg H. Femoral block with mepivacaine for muscle biopsy in malignant hyperthermia patients. Anesthesiology 1985;62:651-2.
27. Paasuke R, Brownell A. Amide local anesthetics and malignant hyperthermia. Can Anaesth Soc J 1986;33:126-9.
28. Felice-Johnson S, Sudds T, Bennett G. Malignant hyperthermia: current perspectives. Am J Hosp Pharmacol 1981;38:646-51.
29. Brebner J, Derdemezi J, MacPherson B, Britt B, Allen G. Malignant hyperthermia protocol. Ontario Med Rev 1992;November:37-9.
30. Wingard D. Malignant hyperthermia: a human stress syndrome? Lancet 1974;2:78-94.
31. Morgenson J, Misfeldt B, Hanel H. Preoperative excitement and malignant hyperthermia. Lancet 1974;1:461.
32. Williams C, Dozier S, Buzello W, et al. Plasma levels of norepinephrine during malignant hyperthermia in susceptible pigs. J Chromatogr Biomed Appl 1985;344:71-80.
33. Fletcher R, Rankley E, Olsson A, Leander S. Malignant hyperthermia syndrome in an anxious patient. Br J Anaesth 1981;53:993-5.
34. Yamashita M, Honda K, Iha H, Kondo SAM, Oyama T. A case of acute hyperpyrexia with violent shivering immediately after operation under epidural anaesthesia supplemented by nitrous oxide. Can Anaesth Soc J 1982;29:632-3.
35. Britt B. Combined anesthetic and stress induced malignant hyperthermia in two offspring of malignant hyperthermic-susceptible parents. Anesth Analg 1988;67:393-9.
36. Gronert G, Thompson R, Onofrio B. Human malignant hyperthermia: awake episodes and correction by dantrolene. Anesth Analg 1980;59:377-8.
37. Feuerman T, Gade G, Reynolds R. Stress-induced malignant hyperthermia in a head-injured patient. J Neurosurg 1988;68:297-9.
38. Hoffman J, Fink H, Patzer H, Till U. Malignant hyperthermia: an update. In: Hoffman J, Schmidt A, eds. Proceedings of the VI Myology Colloquium International Workshop on Malignant Hyperthermia. VEB Verlag: Volk und Gesundheit, 1988:173-5.
39. Kaplan R. Clinical controversies in malignant hyperthermia susceptibility. Anesthesiol Clin N Am 1994;12:537-51.
40. Allen G, Larach M, Kunselman A, et al. The sensitivity and specificity of the caffeine-halothane contracture test. Anesthesiology 1998;88:579-88.
41. Wedel D, Quinlan J, Iaizzo P. Clinical effects of intravenously administered dantrolene. Mayo Clin Proc 1995;70:241-6.
42. Larach M, Simon L, Allen G, et al. Safety and efficacy of dantrolene sodium for the treatment of malignant hyperthermia events. Anesthesiology 1993;79:A1079.
43. Klein J. Tumescent technique for local anesthesia improves safety in large-volume liposuction. Plast Reconstr Surg 1993;92:1085-98.